Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Short-Term Debt issuances (2023)

Journey Medical's Short-Term Debt issuances history spans 1 years, with the latest figure at $28.0 million for Q1 2023.

  • For the quarter ending Q1 2023, Short-Term Debt issuances changed N/A year-over-year to $28.0 million, compared with a TTM value of $28.0 million through Dec 2023, changed N/A, and an annual FY2023 reading of $28.0 million, up 460.0% over the prior year.
  • Short-Term Debt issuances for Q1 2023 was $28.0 million at Journey Medical.
  • The five-year high for Short-Term Debt issuances was $28.0 million in Q1 2023, with the low at $28.0 million in Q1 2023.